Immediate Impact

24 standout
Sub-graph 1 of 12

Citing Papers

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
2024 Standout
Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis
2023 Standout
2 intermediate papers

Works of So Nakaji being referenced

Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
2013

Author Peers

Author Last Decade Papers Cites
So Nakaji 150 139 122 31 317
Diego Coletta 193 73 107 34 300
Miroslav Milićević 225 92 37 24 312
Miguel Bispo 174 66 102 49 341
Sema Arıcı 151 45 86 28 344
Chien‐Chu Lin 117 46 56 22 278
Stefano Amore Bonapasta 218 88 123 23 280
Teresa Rosanna Portale 195 153 105 25 335
İlhan Karabıçak 194 93 77 34 295
Sergio Li Petri 203 53 20 39 269
Ouki Yasui 168 89 129 30 350

All Works

Loading papers...

Rankless by CCL
2026